PTCT (STOCKS)
PTC Therapeutics, Inc.
$67.050000
-3.870000 (-5.46%)
Prev close: $70.920000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew B. Klein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,674.78M
- Employees
- 939
- P/E (TTM)
- 8.29
- P/B (TTM)
- -36.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.20 | $-1.40 | +1.5954 | +114.33% |
|
Jun 2025 (Q2)
|
$-0.83 | $-1.08 | +0.2526 | +23.33% |
|
Mar 2025 (Q1)
|
$10.04 | $-0.22 | +10.2562 | +4,743.85% |
|
Dec 2024 (Q4)
|
$-2.15 | $-0.67 | -1.4809 | -221.33% |
Financial Statements
| Assets | $2.64B |
| Current Assets | $2.01B |
| Accounts Receivable | $203.07M |
| Inventory | $52.69M |
| Other Current Assets | $1.75B |
| Noncurrent Assets | $635.90M |
| Fixed Assets | $56.97M |
| Intangible Assets | $396.47M |
| Other Non-current Assets | $182.46M |
| Liabilities | $2.80B |
| Current Liabilities | $866.25M |
| Accounts Payable | $36.62M |
| Wages | $49.47M |
| Other Current Liabilities | $780.16M |
| Noncurrent Liabilities | $1.93B |
| Equity | -$155.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$155.76M |
| Liabilities And Equity | $2.64B |